No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
MNMD250117C16000
- 0.00
- 0.000.00%
15min DelayTrading Jan 10 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest16.00Strike Price0.00Turnover0.00%IV136.16%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma5.42Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
No Data
News
Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member
Why Mind Medicine Stock Is Soaring Today
Institutional Investors Are Mind Medicine (MindMed) Inc.'s (NASDAQ:MNMD) Biggest Bettors and Were Rewarded After Last Week's US$73m Market Cap Gain
MindMed Stock Skyrockets 94% Year to Date: What's Driving It?
Mind Medicine Price Target Announced at $20.00/Share by Chardan Capital
Mind Medicine Initiated at Buy by Chardan Capital